SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

A bearish BMF short report alleging that SELLASs REGAL Phase 3 trial may be underpowered and that the valuation assumes clinical success triggered the selloff and intensified attention. Traders are divided, with bears citing trial-design and survival concerns while bullish investors dispute the reports statistical interpretation and focus on the pending 80th event and topline readout.

$4CHAN is a meme token on the Ethereum Network.   4ChanToken represents a global crypto community that pays homage to the memetic powerhouses of the internet as Pepe, Doge, Shib and all major memes inventor combining them all into one super meme token that is $4CHAN. At its core, 4ChanToken embodies the untamed spirit of the notorious 4chan imageboard, where iconic memes are born, nurtured, and unleashed upon the world. With an unyielding spirit of irreverence and a touch of mischief, $4CHAN has emerged as the darling of meme enthusiasts, internet dwellers, and crypto aficionados alike.   The foundation of 4ChanToken lies in its community. We’ve harnessed the chaotic energy of this digital realm to create a currency that celebrates the power of memetic expression, empowering users to engage in a truly unique and decentralized economy. As a passionate supporter, you’ll join a vibrant ecosystem where dank memes and viral sensations are the lifeblood of commerce. 4ChanToken is more than just a digital currency – it’s the place where memes are born.  The ultimate playground for memelords and crypto degens. Based on the simplicity of holdrs/volume operating a store of value.  The identification of this value is best described as 'digital gold'. That $4chan can ultimately represent a superior store of value relative to all other forms of memecoins by embodying all memes in one token as the factual birthplace of all popular memes.

4Chan

A speculative burst in the Ethereum-based 4CHAN meme token has drawn attention, with traders citing its extremely low unit price, large supply, claimed locked or burned tokens, and community-driven momentum. Skeptics dispute the liquidity and tokenomics narrative and warn the move could be a pump-and-dump, leaving the discussion divided between aggressive holding and FOMO promotion and scam concerns.

UNI is the governance token for Uniswap, an Automated Market Marker DEX on the Ethereum blockchain. The UNI token allows token holders to participate in the governance of the protocol. Key decisions such as usage of the treasury or future upgrades can be decided through a governance vote.

UniSwap

Attention centers on Uniswaps proposed UNIfication governance plan to activate protocol fees and introduce ongoing UNI burns, potentially improving token value capture and reducing supply. Traders are broadly optimistic, though some question whether the proposal is already priced in and whether the burn will materially change UNIs token economics; Robinhood-related adoption is cited as supporting context.

Atlassian Corp. is a holding company, which engages in providing team collaboration and productivity software. Its products include Jira Software, Confluence, Jira Service Management, and Loom. The company was founded by Michael Cannon-Brookes and Scott Farquhar in October 2002 and is headquartered in San Francisco, CA.

Atlassian Corporation - Ordinary Shares - Class A

Atlassian Corporation Plc

Strong fiscal Q4 results, accelerating cloud growth, and better-than-feared forward guidance have driven renewed enthusiasm for Atlassian as an AI beneficiary rather than an AI-disrupted software company. Traders are broadly bullish and citing short covering and a broader SaaS rotation, while skeptics warn the post-earnings rally is overextended and vulnerable to profit-taking, valuation concerns, and continued Data Center or GAAP profitability issues.

Norwegian Cruise Line Holdings Ltd. engages in the provision of cruise travel services. It offers cruise experiences for travelers with itineraries in Europe, Asia, Australia, New Zealand, South America, Africa, Canada, Bermuda, Caribbean, Alaska and Hawaii. Its brands include Norwegian Cruise Line, Oceania Cruises, and Regent Seven Seas Cruises. The company was founded in 1966 and is headquartered in Miami, FL.

Norwegian Cruise Line Holdings Ltd

A wave of analyst downgrades and concern that Norwegians demand recovery may take longer have pressured the stock, while traders also remain focused on Iran-related oil and Strait of Hormuz risks that could raise cruise fuel costs. The community is split between frustration over weak performance and short-selling or activist-investor speculation, and bullish arguments that falling oil, insider buying, and turnaround efforts support a rebound.

Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. It focuses on building platforms for oncology, neuropsychiatry, cardiology, infectious disease, and radiology. The company was founded by Eric Paul Lefkofsky in August 2015 and is headquartered in Chicago, IL.

Tempus AI Inc. - Ordinary Shares - Class A

Tempus AI Inc

Merck and Modernas positive Phase 3 personalized melanoma-vaccine results have focused traders on Tempuss planned Personalis acquisition, which the community views as validation of its precision-oncology strategy. Debate centers on whether the move reflects genuine value or sympathy-driven momentum, with valuation concerns, profit-taking, and reported Cathie Wood and insider selling adding pressure.

Adobe, Inc. is a global technology company, which engages in the provision of digital marketing and media solutions. It operates through the following segments: Digital Media, Digital Experience, and Publishing and Advertising. The Digital Media segment offers products and services that enable individuals, teams, businesses, and enterprises to create, publish, and promote content anywhere and accelerate productivity by transforming view, share, engage with and collaborate on documents and creative content. The Digital Experience segment focuses on integrated platform and set of products, services, and solutions that enable businesses to create, manage, execute, measure, monetize, and optimize customer experiences that span from analytics to commerce. The Publishing and Advertising segment includes legacy products and services that address diverse market opportunities, including eLearning solutions, technical document publishing, web conferencing, document and forms platform, web app development, high-end printing, and Adobe Advertising offerings. The company was founded by Charles M. Geschke and John E. Warnock in December 1982 and is headquartered in San Jose, CA.

Adobe Inc

A broad rebound in beaten-down software and SaaS stocks, alongside optimism that Adobes AI tools can strengthen rather than disrupt its business, is driving attention. Traders remain divided, with bulls citing Adobes valuation, cash generation and technical recovery while bears point to AI-native competition, Figma and earnings risk.

Strategy, Inc. engages in the development of fixed-income instruments that provide investors varying degrees of economic exposure to bitcoin. It executes bitcoin acquisition, capital management, and capital markets strategies. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

A sharp Bitcoin pullback following Federal Reserve Chair Kevin Warshs hawkish inflation comments is weighing on Strategy, which traders view as a leveraged Bitcoin proxy. The community is split between dip buyers expecting a rebound with Bitcoin and skeptics focused on recent share dilution, capital raises, and continued downside risk.

Joby Aviation, Inc. is a transportation company, which engages in developing an all-electric, vertical take-off and landing aircraft that intends to operate as a commercial passenger aircraft. The company was founded by Bevirt Joebenn in 2009 and is headquartered in Santa Cruz, CA.

Joby Aviation Inc

Jobys planned acquisition of defense-electronics firm Resonant Sciences, alongside a new at-the-market equity program, is driving attention and recent weakness. Traders are divided between viewing the deal as a way to diversify into defense and add revenue, and criticizing the cash outlay, dilution risk, and potential distraction from FAA certification and commercial air-taxi launches.

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and fibre channel storage area networking business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

Broadcoms scheduled earnings report is the dominant catalyst, with traders focusing on whether AI-custom-chip demand, hyperscaler spending and networking momentum will support a strong outlook after Nvidia and Marvells results. Bullish participants expect a beat and renewed AI enthusiasm, while skeptics argue expectations are already elevated and cite debt concerns, Google-related competition and the risk of another post-earnings selloff.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Gilead, Merck, Eli Lilly Lead $106B Biopharma Takeover Wave In 2026

Equity

Biopharma M&A has surged to $106 billion across 201 deals through early June 2026, putting the sector on track for its strongest full-year total since the 2019 pre-pandemic peak, CNBC reported.

Bright Horizons Family Solutions and Remitly Global Set to Join S&P SmallCap 600

Bright Horizons Family Solutions and Remitly Global Set to Join S&P SmallCap 600 Bright Horizons Family Solutions and Remitly Global Set to Join S&P SmallCap 600 PR Newswire NEW YORK, May 7, 2026 NEW...

Compared to Estimates, Apellis Pharmaceuticals (APLS) Q1 Earnings: A Look at Key Metrics

The headline numbers for Apellis Pharmaceuticals (APLS) give insight into how the company performed in the quarter ended March 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Apellis Pharmaceuticals, Inc. (APLS) Tops Q1 Earnings and Revenue Estimates

Apellis Pharmaceuticals (APLS) delivered earnings and revenue surprises of +139.30% and +33.65%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Apellis Pharmaceuticals (NASDAQ:APLS) Reaches New 52-Week High - Here's What Happened

Apellis Pharmaceuticals (NASDAQ:APLS) Sets New 12-Month High - What's Next...

Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) Receives Consensus Recommendation of "Hold" from Analysts

Shares of Apellis Pharmaceuticals, Inc. (NASDAQ:APLS - Get Free Report) have been assigned an average recommendation of "Hold" from the twenty-three ratings firms that are presently covering the company, MarketBeat Ratings reports. Two analysts have rated the stock with a sell rating, eighteen have...

Top 3 Health Care Stocks That May Collapse This Month

Stocks AVNS, APLS, and CERS in healthcare sector flashing warning to momentum-sensitive investors. High RSI values & price action indicate overbought conditions. AVNS at 90. APLS at 86. CERS at 86...

Pictet Asset Management Holding SA Has $9.84 Million Stock Holdings in Apellis Pharmaceuticals, Inc. $APLS

Pictet Asset Management Holding SA grew its holdings in Apellis Pharmaceuticals, Inc. (NASDAQ:APLS - Free Report) by 7.5% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 390,884 shares of the company's stock after acquiring an...

UBS Group AG Boosts Stake in Apellis Pharmaceuticals, Inc. $APLS

UBS Group AG raised its holdings in Apellis Pharmaceuticals, Inc. (NASDAQ:APLS - Free Report) by 22.1% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 4,186,222 shares of the company's stock after purchasing an additio...

Jennison Associates LLC Reduces Holdings in Apellis Pharmaceuticals, Inc. $APLS

Jennison Associates LLC cut its stake in shares of Apellis Pharmaceuticals, Inc. (NASDAQ:APLS - Free Report) by 65.4% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,504,299 shares of the company's stock after selling 2,843...

• Reported GAAP EPS of -$0.47 down -62.07% YoY
• Reported revenue of $199.91M down -5.94% YoY
• Apellis Pharmaceuticals Inc. anticipates its cash and cash equivalents, combined with projected sales from EMPAVELI and SYFOVRE, will fund operating expenses and capital expenditures for at least the next 12 months.

Apellis Pharmaceuticals Inc. faces ongoing losses and significant competition, alongside regulatory uncertainties that could delay approvals and limit market acceptance of its key products.

Apellis Pharmaceuticals Inc. has successfully commercialized two key drugs, is advancing its pipeline with next-generation therapies, and initiated pivotal trials for EMPAVELI in rare nephrology conditions.

Apellis Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs. Its products include EMPAVELI and SYFOVRE. The company was founded by Candace Rose Depp, Pascal Deschatelets, Cedric Francois, and Alec Machiels on September 25, 2009 and is headquartered in Waltham, MA.

Apellis Pharmaceuticals Inc

Bullish Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

The S&P 500 ($SPY) is headed towards a positive week. What do you think the index's return will look like next week? Vote and explain your reasoning in the comments.

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Feed

News

Sentiment

Earnings

Fundamentals

Info

APLS Apellis Pharmaceuticals Inc

Fundamentals

Connect Stocktwits to ChatGPT

Latest APLS News